Leslie Eldeiry is an Endocrinology/Metabolic physician affiliated with Harvard University. OpenAlex indexes 26 publications with 2,302 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
133 Brookline Ave Fl 9
Boston, MA 022153904
Telephone
617-421-1380Provider last certified this registry record 5 Jan 2026.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year20251 payment
- Amgen Inc.Program year20241 payment
- Medtronic, Inc.Program year20233 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Musculoskeletal
55.6%RANK Ligand Inhibitor52.1%Denosumab100%Part B, office-administered≥26 patientsBisphosphonate3.1%Zoledronic acid100%Part B, office-administered≥33 patients+ 1 more class in this area
Metabolism & gastrointestinal
26.3%GLP-1 receptor agonist8.1%Ozempic55%Mounjaro18%Trulicity17%Rybelsus10%Part D≥41 patientsInsulin Analog8.1%Lantus Solostar27%Humalog Kwikpen U-10018%Basaglar Kwikpen U-10010%Novolog Flexpen8%Novolog7%Lantus6%Tresiba Flextouch U-1006%Fiasp Flextouch5%Admelog Solostar4%Humalog3%Semglee (Yfgn) Pen3%Humalog Kwikpen U-2003%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
15.4%l-Thyroxine12.5%Levothyroxine Sodium81%Synthroid11%Levoxyl8%Part D≥141 patientsThyroid Hormone Synthesis Inhibitor2%Methimazole90%Propylthiouracil10%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- MON-808 Multiple Vertebral Fractures After A Single Dose Of Denosumab
Journal of the Endocrine Society
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Benjamin Ebert, MD
Harvard University
Mark Shrime, MD
Harvard University
Thoralf Sundt, MD
Harvard University
Dhaval Kolte, MBBS, PhD
Harvard University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”